Desmoplakin Cardiomyopathy: Role of Inflammation and Potential Role of Disease-Modifying Therapies.

导出 LinkOut

翻译打印收藏纠错

作者： Alessio,Gasperetti ^[1] ; Richard T,Carrick ^[2] ; Steven,Muller ^[3] ; Brittney,Murray ^[2] ; Luigi,Adamo ^[2] ; Barbara,Bauce ^[4] ; Elizabeth,McNally ^[5] ; Adam,Helms ^[6]

作者单位： Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. alessio.gasperetti93@gmail.com. ^[1] Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. ^[2] Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.;Netherlands Heart Institute, Utrecht, the Netherlands. ^[3] Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy. ^[4] Center for Genetic Medicine and Bluhm Cardiovascular Institute, Department of Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. ^[5] Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA. ^[6]

关键词 Arrhythmogenic cardiomyopathy DSP DSP-cardiomyopathy Immunosuppression Myocarditis

主题词人类(Humans);心肌炎(Myocarditis);桥粒斑蛋白质类(Desmoplakins);心肌疾病(Cardiomyopathies);免疫抑制剂(Immunosuppressive Agents);消炎药(Anti-Inflammatory Agents);炎症(Inflammation)

DOI 10.1007/s11886-024-02183-7

PMID 39786454

发布时间 2025-01-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交